On Tuesday, Pfizer Inc (PFE) stock saw a decline, ending the day at $29.18 which represents a decrease of $-0.02 or -0.07% from the prior close of $29.2. The stock opened at $29.21 and touched a low ...

Investing.com -- Pfizer Inc. (NYSE: PFE) shares rose more than 3% on Wednesday following reports that CEO Albert Bourla is ...

With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

Ken Griffin is a billionaire investor who serves as CEO of the hedge fund Citadel. Last quarter, Citadel bought 7.9 million ...

Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...

While Pfizer has made a number of acquisitions, its biggest bet is on Seagen. Pfizer wants this to be a transformative ...

Tencent Health and Pfizer China have launched the "Pfizer Smart Healthcare Innovation Ecosystem" at the "Tides of Qiantang" Conference. This collaboration aims to drive innovation in smart healthcare ...

Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio, both of whom expressed interest in supporting the activist investor's ...

--Pfizer's Chief Executive Albert Bourla plans to meet Starboard Value next week with at least one other director after the activist investor acquired a $1 billion stake in the healthcare company, the ...

Pfizer Inc.’s stock gained Monday after a report that activist investor Starboard Value has invested $1 billion in the drug ...

Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its ...

Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...